216 related articles for article (PubMed ID: 18983830)
21. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.
Yang C; McDonald JG; Patel A; Zhang Y; Umetani M; Xu F; Westover EJ; Covey DF; Mangelsdorf DJ; Cohen JC; Hobbs HH
J Biol Chem; 2006 Sep; 281(38):27816-26. PubMed ID: 16857673
[TBL] [Abstract][Full Text] [Related]
22. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
[TBL] [Abstract][Full Text] [Related]
23. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
24. LXRalpha enhances lipid synthesis in SZ95 sebocytes.
Hong I; Lee MH; Na TY; Zouboulis CC; Lee MO
J Invest Dermatol; 2008 May; 128(5):1266-72. PubMed ID: 17960176
[TBL] [Abstract][Full Text] [Related]
25. 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR.
Trousson A; Bernard S; Petit PX; Liere P; Pianos A; El Hadri K; Lobaccaro JM; Ghandour MS; Raymondjean M; Schumacher M; Massaad C
J Neurochem; 2009 May; 109(4):945-58. PubMed ID: 19250336
[TBL] [Abstract][Full Text] [Related]
26. Ligand specificity and evolution of liver X receptors.
Reschly EJ; Ai N; Welsh WJ; Ekins S; Hagey LR; Krasowski MD
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):83-94. PubMed ID: 18395439
[TBL] [Abstract][Full Text] [Related]
27. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.
Walcher D; Kümmel A; Kehrle B; Bach H; Grüb M; Durst R; Hombach V; Marx N
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1022-8. PubMed ID: 16484597
[TBL] [Abstract][Full Text] [Related]
28. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
[TBL] [Abstract][Full Text] [Related]
29. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
30. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
33. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.
Colin S; Bourguignon E; Boullay AB; Tousaint JJ; Huet S; Caira F; Staels B; Lestavel S; Lobaccaro JM; Delerive P
Endocrinology; 2008 Oct; 149(10):5128-35. PubMed ID: 18566121
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
Qin Y; Dalen KT; Gustafsson JA; Nebb HI
Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
[TBL] [Abstract][Full Text] [Related]
35. Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes.
Madsen L; Petersen RK; Steffensen KR; Pedersen LM; Hallenborg P; Ma T; Frøyland L; Døskeland SO; Gustafsson JA; Kristiansen K
J Biol Chem; 2008 Aug; 283(33):22723-36. PubMed ID: 18487205
[TBL] [Abstract][Full Text] [Related]
36. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin.
Geyeregger R; Zeyda M; Bauer W; Kriehuber E; Säemann MD; Zlabinger GJ; Maurer D; Stulnig TM
Blood; 2007 May; 109(10):4288-95. PubMed ID: 17255360
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
38. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
Mitro N; Vargas L; Romeo R; Koder A; Saez E
FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
[TBL] [Abstract][Full Text] [Related]
39. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
40. Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice.
Mouzat K; Volat F; Baron S; Alves G; Pommier AJ; Volle DH; Marceau G; DeHaze A; Déchelotte P; Duggavathi R; Caira F; Lobaccaro JM
Endocrinology; 2009 Jul; 150(7):3369-75. PubMed ID: 19325005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
